The involvement of reactive oxygen species (ROS) in killing by bactericidal antibiotics is actively debated. In this article, the authors demonstrate that ROS production contributes to the antimicrobial activity of ciprofloxacin against biofilm-grown Pseudomonas aeruginosa cells. Results of this work shed light on the antibiofilm mode of action of ciprofloxacin, but at the same time raises the concern that increased mutation rate due to oxidative DNA damage could lead to multidrug resistance. 
Abstract
Antibiotic-tolerant, biofilm-forming Pseudomonas aeruginosa has long been recognized as a major cause of chronic lung infections of cystic fibrosis patients. The mechanisms involved in the activity of antibiotics on biofilm are not completely clear. We have investigated whether the proposed induction of cytotoxic hydroxyl radicals (OH˙) during antibiotic treatment of planktonically grown cells may contribute to action of the commonly used antibiotic ciprofloxacin on P. aeruginosa biofilms. For this purpose, WT PAO1, a catalase deficient DkatA and a ciprofloxacin resistant mutant of PAO1 (gyrA), were grown as biofilms in microtiter plates and treated with ciprofloxacin. Formation of OH˙and total amount of reactive oxygen species (ROS) was measured and viability was estimated. Formation of OH˙and total ROS in PAO1 biofilms treated with ciprofloxacin was shown but higher levels were measured in DkatA biofilms, and no ROS production was seen in the gyrA biofilms. Treatment with ciprofloxacin decreased the viability of PAO1 and DkatA biofilms but not of gyrA biofilms. Addition of thiourea, a OHṡ cavenger, decreased the OH˙levels and killing of PAO1 biofilm. Our study shows that OH˙is produced by P. aeruginosa biofilms treated with ciprofloxacin, which may contribute to the killing of biofilm subpopulations.
Pseudomonas aeruginosa is a Gram-negative proteobacterium, which dominates chronic lung infections in patients with cystic fibrosis (CF) (Høiby et al., 2010a, b) . The chronic P. aeruginosa lung infection in patients with CF is characterized by the presence of endobronchial biofilm surrounded by numerous polymorphonuclear leukocytes (PMNs) (Bjarnsholt et al., 2009; Kolpen et al., 2010) . Despite the bactericidal activity of the PMNs and intensive antibiotic therapy, these biofilms persist and grow in the endobronchial mucus of patients with CF over many years (Bjarnsholt et al., 2009) .
Biofilms formation dramatically increases the tolerance of P. aeruginosa toward most antibiotics (Høiby et al., 2010a, b) . The increased tolerance of biofilm may result from reduced drug penetration in the biofilms, lower growth rate of sessile cells and the expression of specific resistance mechanisms (Høiby et al., 2010a, b) . The actual mechanisms involved in the activity of antibiotics on biofilm are, however, far from fully understood. Recently, Kohanski et al. (2007) demonstrated that different classes of bactericidal antibiotics induce production of reactive oxygen species (ROS) including formation of cytotoxic hydroxyl radicals (OH˙) that contributes to the antimicrobial bactericidal activity in Escherichia coli and Staphylococcus aureus. According to the proposed bacterial killing model, both superoxide (O À 2 ) and hydrogen peroxide (H 2 O 2 ) formation are involved in the production of bactericidal amounts of OH ( Kohanski et al., 2010a) . While O À 2 and H 2 O 2 can be enzymatically eradicated by superoxide dismutases, catalases and peroxidases, no known enzyme is able to catalyze the cellular detoxification of OH˙, which may induce lethal oxidative lesions on proteins, lipids and DNA (Imlay, 2003 ).
Kohanski's work has recently been questioned (Keren et al., 2013; Liu & Imlay, 2013) ; however, our results are in agreement with Kohanski et al. (2007) , and we have demonstrated that cytotoxic amounts of OH˙are produced in planktonically growing P. aeruginosa during treatment with ciprofloxacin in bactericidal concentrations of aerobic cultures (Brochmann et al., 2013) .
As biofilms may contain aerobic zones with growth (Stewart & Franklin, 2008) , we speculated that cytotoxic amounts of OH˙are also produced in P. aeruginosa biofilms during ciprofloxacin treatment.
The strains used in this work were the wild-type P. aeruginosa strain PAO1 obtained from the Pseudomonas Genetic Stock Center (www.pseudomonas.med.ecu.edu; strain PAO0001), a catalase A negative PAO1 (DkatA; Hassett et al., 1999) mutant and a ciprofloxacin resistant mutant of PAO1 (gyrA). The ciprofloxacin resistant mutant was isolated from an in vitro long-term experiment in which PAO1 has been exposed to subinhibitory concentrations of ciprofloxacin (Jørgensen et al., 2013) . The mechanism of ciprofloxacin resistance is due to a C248T mutation causing change in amino acid Ser83 in gyrA. The MIC of ciprofloxacin to PAO1, DkatA and gyrA were 0.125, 0.094 and 32 mg L À1 , respectively, as measured by E-test. All strains were cultured at 37°C on blue lactose agar plates (a modified ConradiDrigalski medium selective for Gram-negative rods, State Serum Institute, Copenhagen, Denmark). Overnight cultures were grown from one colony diluted in Luria-Bertani broth and incubated aerobically at 37°C.
Two hundred microliter of overnight cultures with an OD 600 adjusted to 0.4 before 100-fold dilution in AB minimal medium (Clark & Maaløe, 1967) supplemented with trace metals and 0.5% (w/v) glucose (ABTG) were added to each well of black microtiter plates with transparent flat bottom (16503, Thermo Fisher Scientific, Rochester, NY). After 24 or 72 h, the supernatant was replaced by 200 lL of a ciprofloxacin (Bayer, Leverkusen, Germany) solution in ABTG (with and without 100 mM thiourea (Sigma, Brøndby, Denmark) in following twofold dilution concentrations from 0.016 to 8 mg L À1 (Setsukinai et al., 2003) , and the plates were further incubated at 37°C overnight. After incubation, the fluorescence from the OH • indicator and the ROS indicator was recorded in a plate reader (Wallac 1420, Victor X3, Perkin Elmer, MA). The excitation/ emission wavelengths were 485/510 for HPF and 485/ 535 nm for DCFH-DA.
Estimation of the bacterial viability according to the ATP content was performed with the BacTiter-Glo kit (Promega, Madison, WI) following the manufacturer's protocol. The chemiluminescence was measured in a plate reader (Wallac 1420).
Results from three to five individual experimental setups with triplicates were evaluated for normality by D'AgostinoPearson omnibus test. One-way analysis of variance (ANOVA) by Holm-Sidak test corrected by Dunnett's multiple comparison test was performed on sets of data that passed the normality test. For comparisons of data that did not pass the normality test, a Friedman test corrected by Dunn's multiple comparison test was performed. A P-value of P ≤ 0.05 was considered statistically significant. The statistical tests were performed with PRISM 6.0c (GraphPad Software, La Jolla, CA) and EXCEL (Microsoft Office 2007, Redmond, WA).
As originally described in planktonic bacteria (Kohanski et al., 2007) , increased OH
• and total ROS production during ciprofloxacin treatment of PAO1 biofilms were observed in this study. The increase in OH
• and total ROS was accompanied by a decrease in biofilm viability. ROS production was, however, increased even at subinhibitory concentrations of ciprofloxacin as seen at 0.125 mg L À1 in Fig. 1 . These results point to ROS production during sublethal dosis of ciprofloxacin as well as during treatment with lethal dosis of ciprofloxacin. To relate the increase in OH
• production with the decreased viability, OH • was scavenged with thiourea (Novogrodsky et al., 1982) during the ciprofloxacin treatment of PAO1 biofilms. Figure 1 shows that the addition of thiourea reduced HPF and DCHF-DA fluorescence and partly preserved the viability of the biofilm, indicating that OH
• formation contributes to the killing of biofilm growing P. aeruginosa during ciprofloxacin treatment. The involvement of OH
• induction in the killing activity of ciprofloxacin was additionally supported by the lack of OH
• and total ROS production during treatment with ciprofloxacin of the gyrA biofilm. To further verify the contribution of OH
• induction to the activity of ciprofloxacin, we decided to include a biofilm with deficient antioxidative defense. The catalase encoded by the katA gene is responsible for a major part of the detoxification of ROS in P. aeruginosa (Hassett & Cohen, 1989; Hassett et al., 1999) . In our study, the DkatA mutant biofilm had increased susceptibility and increased production of OH
• and total ROS during ciprofloxacin treatment (Fig. 1) . This is in accordance to the inability of this mutant to quench H 2 O 2 as shown by Stewart (Stewart et al., 2000) . Evidence for the involvement of ROS in the tolerance of biofilms to antibiotics has been also shown in Burkholderia cenocepacia (Van Acker et al., 2013) . Survival of biofilm-grown B. cenocepacia was increased during tobramycin treatment when the level of ROS was decreased by downregulating the tricarboxylic acid cycle. In contrast, the survival of the biofilm during tobramycin treatment was decreased in catalase mutants (DkatA and DkatB) that exhibit higher levels of ROS (Van Acker et al., 2013) .
Recent studies, however, point to the existence of antibiotic killing mechanisms that are not dependent on OH
• induction in bacteria (Brochmann et al., 2013; Keren et al., 2013; Liu & Imlay, 2013) . For ciprofloxacin, this fits into a scheme containing two lethal pathways of quinolones: one is blocked by inhibitors of protein synthesis and by anaerobic conditions (the chloramphenicol-sensitive, ROS-dependent) and another is active even in the presence of protein synthesis inhibitors or the absence of oxygen (the chloramphenicol-insensitive, ROS-independent), as described in planktonic cultures of E. coli (Drlica et al., 2009) . Lethal effects of quinolones in the chloramphenicol-sensitive pathway, which are seen when the drug concentration is higher than the bacteriostatic levels, correlate with chromosome fragmentation (Malik et al., 2006) , and that fragmentation appears to lead to production of superoxide, which dismutates to hydrogen peroxide. Hydrogen peroxide then generates highly toxic OH
• through the Fenton reaction. The chloramphenicol-insensitive pathway may explain the moderate bactericidal effect of ciprofloxacin on anaerobically growing planktonic P. aeruginosa (Brochmann et al., 2013) .
Both pathways probably play a role in the treatment of biofilms in the chronic P. aeruginosa lung infection in patients with CF, as both aerobic and anaerobic niches are present in the heterogeneous macroenvironment in the CF respiratory tract . Our group has previously shown by confocal laser scanning microscopy that ciprofloxacin can kill the surface layer of P. aeruginosa biofilms, whereas bacteria in the deep layer of the biofilms are resistant (Pamp et al., 2008) .
The increased tolerance of mature biofilm against antibiotics has emphasized the importance of early treatment and correct choice of antibiotics for P. aeruginosa biofilm infections (Bowler et al., 2012) . Three-day-old biofilms were significantly more tolerant to treatment with 8 mg L À1 ciprofloxacin than one-day-old biofilms: the surviving fraction 38% compared with 19%, P < 0.001). This suggests that larger proportions of mature biofilms are protected against the activity of ciprofloxacin. We propose that induction of Fig. 1 Measurements of HPF fluorescence, DCHF-DA fluorescence and ATP-mediated chemiluminescence in 1-and 3-day-old biofilm treated with ciprofloxacin over night. Mean AE SEM of triplicates from 3 to 5 individual experiments are shown. Intervals of significant changes by ciprofloxacin treatment are indicated by the dashed lines. Statistical analysis by one-way ANOVA with Dunnett's multiple comparisons test except for the ATP-mediated chemiluminescence of the gyrA, which was analyzed by Friedman test corrected by Dunn's multiple comparison test due to lack of normality. P ≤ 0.05 was considered significant. cytotoxic amounts of OH
• during ciprofloxacin treatment is prevented in parts of the biofilm with low metabolic activity or anaerobic conditions, because we have recently observed that nutrient deprivation and oxygen depletion reduce the killing activity and the ability to induce OH
• of ciprofloxacin during treatment for planktonic P. aeruginosa. (Brochmann et al., 2013) . Likewise, tolerance in E. coli biofilm is attenuated by addition of metabolites that restore the ability to generate OH
• by hyperoxidation of NADH derived from the tricarboxylic acid cycle (Allison et al., 2011) .
In conclusion, our results show that ciprofloxacin induces production of OH
• in P. aeruginosa biofilms, and this production of oxidative radicals contributes to the killing effect of ciprofloxacin. Multiresistance may be induced by oxidative DNA lesions caused by the nontoxic amounts of OH
• produced by P. aeruginosa biofilms treated with sublethal concentrations of ciprofloxacin (Kohanski et al., 2010b; Jørgensen et al., 2013) , leading to treatment failure. Further investigations are needed to shed light on the effects of antibiotics and the behavior of bacterial cells in biofilm in order to find new strategies to treat this complex bacterial community.
